line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,CONCORDBIO.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.248529,CONCORDBIO.NS
Normalized EBITDA,2025-03-31 00:00:00,5494561000.0,CONCORDBIO.NS
Total Unusual Items,2025-03-31 00:00:00,,CONCORDBIO.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,CONCORDBIO.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Reconciled Depreciation,2025-03-31 00:00:00,543735000.0,CONCORDBIO.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,3055131000.0,CONCORDBIO.NS
EBITDA,2025-03-31 00:00:00,5494561000.0,CONCORDBIO.NS
EBIT,2025-03-31 00:00:00,4950826000.0,CONCORDBIO.NS
Net Interest Income,2025-03-31 00:00:00,-5293000.0,CONCORDBIO.NS
Interest Expense,2025-03-31 00:00:00,5293000.0,CONCORDBIO.NS
Interest Income,2025-03-31 00:00:00,,CONCORDBIO.NS
Normalized Income,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Total Expenses,2025-03-31 00:00:00,7481289000.0,CONCORDBIO.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,CONCORDBIO.NS
Diluted Average Shares,2025-03-31 00:00:00,,CONCORDBIO.NS
Basic Average Shares,2025-03-31 00:00:00,,CONCORDBIO.NS
Diluted EPS,2025-03-31 00:00:00,,CONCORDBIO.NS
Basic EPS,2025-03-31 00:00:00,,CONCORDBIO.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Net Income Common Stockholders,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,CONCORDBIO.NS
Net Income,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Net Income Continuous Operations,2025-03-31 00:00:00,3716423000.0,CONCORDBIO.NS
Tax Provision,2025-03-31 00:00:00,1229110000.0,CONCORDBIO.NS
Pretax Income,2025-03-31 00:00:00,4945533000.0,CONCORDBIO.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,444467000.0,CONCORDBIO.NS
Special Income Charges,2025-03-31 00:00:00,,CONCORDBIO.NS
Other Special Charges,2025-03-31 00:00:00,,CONCORDBIO.NS
Write Off,2025-03-31 00:00:00,,CONCORDBIO.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-5293000.0,CONCORDBIO.NS
Total Other Finance Cost,2025-03-31 00:00:00,,CONCORDBIO.NS
Interest Expense Non Operating,2025-03-31 00:00:00,5293000.0,CONCORDBIO.NS
Interest Income Non Operating,2025-03-31 00:00:00,,CONCORDBIO.NS
Operating Income,2025-03-31 00:00:00,4519580000.0,CONCORDBIO.NS
Operating Expense,2025-03-31 00:00:00,4426158000.0,CONCORDBIO.NS
Other Operating Expenses,2025-03-31 00:00:00,2493087000.0,CONCORDBIO.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,543735000.0,CONCORDBIO.NS
Amortization,2025-03-31 00:00:00,,CONCORDBIO.NS
Depreciation Income Statement,2025-03-31 00:00:00,543735000.0,CONCORDBIO.NS
Selling General And Administration,2025-03-31 00:00:00,,CONCORDBIO.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,CONCORDBIO.NS
General And Administrative Expense,2025-03-31 00:00:00,,CONCORDBIO.NS
Rent And Landing Fees,2025-03-31 00:00:00,,CONCORDBIO.NS
Gross Profit,2025-03-31 00:00:00,8945738000.0,CONCORDBIO.NS
Cost Of Revenue,2025-03-31 00:00:00,3055131000.0,CONCORDBIO.NS
Total Revenue,2025-03-31 00:00:00,12000869000.0,CONCORDBIO.NS
Operating Revenue,2025-03-31 00:00:00,12000869000.0,CONCORDBIO.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,CONCORDBIO.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.253201,CONCORDBIO.NS
Normalized EBITDA,2024-03-31 00:00:00,4687084000.0,CONCORDBIO.NS
Total Unusual Items,2024-03-31 00:00:00,142180000.0,CONCORDBIO.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,142180000.0,CONCORDBIO.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Reconciled Depreciation,2024-03-31 00:00:00,535915000.0,CONCORDBIO.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,2291981000.0,CONCORDBIO.NS
EBITDA,2024-03-31 00:00:00,4687084000.0,CONCORDBIO.NS
EBIT,2024-03-31 00:00:00,4151169000.0,CONCORDBIO.NS
Net Interest Income,2024-03-31 00:00:00,-25519000.0,CONCORDBIO.NS
Interest Expense,2024-03-31 00:00:00,25519000.0,CONCORDBIO.NS
Interest Income,2024-03-31 00:00:00,30411000.0,CONCORDBIO.NS
Normalized Income,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Total Expenses,2024-03-31 00:00:00,6389736000.0,CONCORDBIO.NS
Rent Expense Supplemental,2024-03-31 00:00:00,85581000.0,CONCORDBIO.NS
Diluted Average Shares,2024-03-31 00:00:00,104619083.0,CONCORDBIO.NS
Basic Average Shares,2024-03-31 00:00:00,104619083.0,CONCORDBIO.NS
Diluted EPS,2024-03-31 00:00:00,29.45,CONCORDBIO.NS
Basic EPS,2024-03-31 00:00:00,29.45,CONCORDBIO.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Net Income Common Stockholders,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,CONCORDBIO.NS
Net Income,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Net Income Continuous Operations,2024-03-31 00:00:00,3081032000.0,CONCORDBIO.NS
Tax Provision,2024-03-31 00:00:00,1044618000.0,CONCORDBIO.NS
Pretax Income,2024-03-31 00:00:00,4125650000.0,CONCORDBIO.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,337800000.0,CONCORDBIO.NS
Special Income Charges,2024-03-31 00:00:00,1533000.0,CONCORDBIO.NS
Other Special Charges,2024-03-31 00:00:00,-1533000.0,CONCORDBIO.NS
Write Off,2024-03-31 00:00:00,,CONCORDBIO.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-25519000.0,CONCORDBIO.NS
Total Other Finance Cost,2024-03-31 00:00:00,6321000.0,CONCORDBIO.NS
Interest Expense Non Operating,2024-03-31 00:00:00,25519000.0,CONCORDBIO.NS
Interest Income Non Operating,2024-03-31 00:00:00,30411000.0,CONCORDBIO.NS
Operating Income,2024-03-31 00:00:00,3779656000.0,CONCORDBIO.NS
Operating Expense,2024-03-31 00:00:00,4097755000.0,CONCORDBIO.NS
Other Operating Expenses,2024-03-31 00:00:00,2331373000.0,CONCORDBIO.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,535915000.0,CONCORDBIO.NS
Amortization,2024-03-31 00:00:00,3388000.0,CONCORDBIO.NS
Depreciation Income Statement,2024-03-31 00:00:00,535915000.0,CONCORDBIO.NS
Selling General And Administration,2024-03-31 00:00:00,442383000.0,CONCORDBIO.NS
Selling And Marketing Expense,2024-03-31 00:00:00,331096000.0,CONCORDBIO.NS
General And Administrative Expense,2024-03-31 00:00:00,111287000.0,CONCORDBIO.NS
Rent And Landing Fees,2024-03-31 00:00:00,85581000.0,CONCORDBIO.NS
Gross Profit,2024-03-31 00:00:00,7877411000.0,CONCORDBIO.NS
Cost Of Revenue,2024-03-31 00:00:00,2291981000.0,CONCORDBIO.NS
Total Revenue,2024-03-31 00:00:00,10169392000.0,CONCORDBIO.NS
Operating Revenue,2024-03-31 00:00:00,10169392000.0,CONCORDBIO.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,10863104.0,CONCORDBIO.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.256,CONCORDBIO.NS
Normalized EBITDA,2023-03-31 00:00:00,3763127000.0,CONCORDBIO.NS
Total Unusual Items,2023-03-31 00:00:00,42434000.0,CONCORDBIO.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,42434000.0,CONCORDBIO.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Reconciled Depreciation,2023-03-31 00:00:00,540324000.0,CONCORDBIO.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,1970667000.0,CONCORDBIO.NS
EBITDA,2023-03-31 00:00:00,3805561000.0,CONCORDBIO.NS
EBIT,2023-03-31 00:00:00,3265237000.0,CONCORDBIO.NS
Net Interest Income,2023-03-31 00:00:00,-7437000.0,CONCORDBIO.NS
Interest Expense,2023-03-31 00:00:00,45103000.0,CONCORDBIO.NS
Interest Income,2023-03-31 00:00:00,44408000.0,CONCORDBIO.NS
Normalized Income,2023-03-31 00:00:00,2369286104.0,CONCORDBIO.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Total Expenses,2023-03-31 00:00:00,5258865000.0,CONCORDBIO.NS
Rent Expense Supplemental,2023-03-31 00:00:00,58980000.0,CONCORDBIO.NS
Diluted Average Shares,2023-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Basic Average Shares,2023-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Diluted EPS,2023-03-31 00:00:00,22.949189,CONCORDBIO.NS
Basic EPS,2023-03-31 00:00:00,22.949189,CONCORDBIO.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Net Income Common Stockholders,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,CONCORDBIO.NS
Net Income,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Net Income Continuous Operations,2023-03-31 00:00:00,2400857000.0,CONCORDBIO.NS
Tax Provision,2023-03-31 00:00:00,819277000.0,CONCORDBIO.NS
Pretax Income,2023-03-31 00:00:00,3220134000.0,CONCORDBIO.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,15872000.0,CONCORDBIO.NS
Special Income Charges,2023-03-31 00:00:00,5265000.0,CONCORDBIO.NS
Other Special Charges,2023-03-31 00:00:00,-5265000.0,CONCORDBIO.NS
Write Off,2023-03-31 00:00:00,0.0,CONCORDBIO.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-7437000.0,CONCORDBIO.NS
Total Other Finance Cost,2023-03-31 00:00:00,6742000.0,CONCORDBIO.NS
Interest Expense Non Operating,2023-03-31 00:00:00,45103000.0,CONCORDBIO.NS
Interest Income Non Operating,2023-03-31 00:00:00,44408000.0,CONCORDBIO.NS
Operating Income,2023-03-31 00:00:00,3047457000.0,CONCORDBIO.NS
Operating Expense,2023-03-31 00:00:00,3288198000.0,CONCORDBIO.NS
Other Operating Expenses,2023-03-31 00:00:00,1551033000.0,CONCORDBIO.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,540324000.0,CONCORDBIO.NS
Amortization,2023-03-31 00:00:00,33794000.0,CONCORDBIO.NS
Depreciation Income Statement,2023-03-31 00:00:00,506530000.0,CONCORDBIO.NS
Selling General And Administration,2023-03-31 00:00:00,342004000.0,CONCORDBIO.NS
Selling And Marketing Expense,2023-03-31 00:00:00,236985000.0,CONCORDBIO.NS
General And Administrative Expense,2023-03-31 00:00:00,105019000.0,CONCORDBIO.NS
Rent And Landing Fees,2023-03-31 00:00:00,58980000.0,CONCORDBIO.NS
Gross Profit,2023-03-31 00:00:00,6335655000.0,CONCORDBIO.NS
Cost Of Revenue,2023-03-31 00:00:00,1970667000.0,CONCORDBIO.NS
Total Revenue,2023-03-31 00:00:00,8306322000.0,CONCORDBIO.NS
Operating Revenue,2023-03-31 00:00:00,8306322000.0,CONCORDBIO.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-2516425.0,CONCORDBIO.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.2635,CONCORDBIO.NS
Normalized EBITDA,2022-03-31 00:00:00,2940070000.0,CONCORDBIO.NS
Total Unusual Items,2022-03-31 00:00:00,-9550000.0,CONCORDBIO.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-9550000.0,CONCORDBIO.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Reconciled Depreciation,2022-03-31 00:00:00,500500000.0,CONCORDBIO.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,1779230000.0,CONCORDBIO.NS
EBITDA,2022-03-31 00:00:00,2930520000.0,CONCORDBIO.NS
EBIT,2022-03-31 00:00:00,2430020000.0,CONCORDBIO.NS
Net Interest Income,2022-03-31 00:00:00,-13480000.0,CONCORDBIO.NS
Interest Expense,2022-03-31 00:00:00,54840000.0,CONCORDBIO.NS
Interest Income,2022-03-31 00:00:00,47870000.0,CONCORDBIO.NS
Normalized Income,2022-03-31 00:00:00,1756323575.0,CONCORDBIO.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Total Expenses,2022-03-31 00:00:00,4723130000.0,CONCORDBIO.NS
Rent Expense Supplemental,2022-03-31 00:00:00,20000.0,CONCORDBIO.NS
Diluted Average Shares,2022-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Basic Average Shares,2022-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Diluted EPS,2022-03-31 00:00:00,16.721023,CONCORDBIO.NS
Basic EPS,2022-03-31 00:00:00,16.721023,CONCORDBIO.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,CONCORDBIO.NS
Net Income,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1749290000.0,CONCORDBIO.NS
Tax Provision,2022-03-31 00:00:00,625890000.0,CONCORDBIO.NS
Pretax Income,2022-03-31 00:00:00,2375180000.0,CONCORDBIO.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,9730000.0,CONCORDBIO.NS
Special Income Charges,2022-03-31 00:00:00,-61850000.0,CONCORDBIO.NS
Other Special Charges,2022-03-31 00:00:00,-2690000.0,CONCORDBIO.NS
Write Off,2022-03-31 00:00:00,64540000.0,CONCORDBIO.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-13480000.0,CONCORDBIO.NS
Total Other Finance Cost,2022-03-31 00:00:00,6510000.0,CONCORDBIO.NS
Interest Expense Non Operating,2022-03-31 00:00:00,54840000.0,CONCORDBIO.NS
Interest Income Non Operating,2022-03-31 00:00:00,47870000.0,CONCORDBIO.NS
Operating Income,2022-03-31 00:00:00,2361270000.0,CONCORDBIO.NS
Operating Expense,2022-03-31 00:00:00,2943900000.0,CONCORDBIO.NS
Other Operating Expenses,2022-03-31 00:00:00,1264900000.0,CONCORDBIO.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,500500000.0,CONCORDBIO.NS
Amortization,2022-03-31 00:00:00,33950000.0,CONCORDBIO.NS
Depreciation Income Statement,2022-03-31 00:00:00,466550000.0,CONCORDBIO.NS
Selling General And Administration,2022-03-31 00:00:00,320170000.0,CONCORDBIO.NS
Selling And Marketing Expense,2022-03-31 00:00:00,214360000.0,CONCORDBIO.NS
General And Administrative Expense,2022-03-31 00:00:00,105810000.0,CONCORDBIO.NS
Rent And Landing Fees,2022-03-31 00:00:00,20000.0,CONCORDBIO.NS
Gross Profit,2022-03-31 00:00:00,5305170000.0,CONCORDBIO.NS
Cost Of Revenue,2022-03-31 00:00:00,1779230000.0,CONCORDBIO.NS
Total Revenue,2022-03-31 00:00:00,7084400000.0,CONCORDBIO.NS
Operating Revenue,2022-03-31 00:00:00,7084400000.0,CONCORDBIO.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,CONCORDBIO.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,CONCORDBIO.NS
Normalized EBITDA,2021-03-31 00:00:00,,CONCORDBIO.NS
Total Unusual Items,2021-03-31 00:00:00,65010000.0,CONCORDBIO.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,65010000.0,CONCORDBIO.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,CONCORDBIO.NS
Reconciled Depreciation,2021-03-31 00:00:00,,CONCORDBIO.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,CONCORDBIO.NS
EBITDA,2021-03-31 00:00:00,,CONCORDBIO.NS
EBIT,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Interest Income,2021-03-31 00:00:00,,CONCORDBIO.NS
Interest Expense,2021-03-31 00:00:00,,CONCORDBIO.NS
Interest Income,2021-03-31 00:00:00,17870000.0,CONCORDBIO.NS
Normalized Income,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,CONCORDBIO.NS
Total Expenses,2021-03-31 00:00:00,,CONCORDBIO.NS
Rent Expense Supplemental,2021-03-31 00:00:00,40000.0,CONCORDBIO.NS
Diluted Average Shares,2021-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Basic Average Shares,2021-03-31 00:00:00,104616204.0,CONCORDBIO.NS
Diluted EPS,2021-03-31 00:00:00,22.452258,CONCORDBIO.NS
Basic EPS,2021-03-31 00:00:00,22.452258,CONCORDBIO.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,CONCORDBIO.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Income,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,CONCORDBIO.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,CONCORDBIO.NS
Tax Provision,2021-03-31 00:00:00,,CONCORDBIO.NS
Pretax Income,2021-03-31 00:00:00,,CONCORDBIO.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,CONCORDBIO.NS
Special Income Charges,2021-03-31 00:00:00,-4850000.0,CONCORDBIO.NS
Other Special Charges,2021-03-31 00:00:00,-30000.0,CONCORDBIO.NS
Write Off,2021-03-31 00:00:00,4880000.0,CONCORDBIO.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,CONCORDBIO.NS
Total Other Finance Cost,2021-03-31 00:00:00,3810000.0,CONCORDBIO.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,CONCORDBIO.NS
Interest Income Non Operating,2021-03-31 00:00:00,17870000.0,CONCORDBIO.NS
Operating Income,2021-03-31 00:00:00,,CONCORDBIO.NS
Operating Expense,2021-03-31 00:00:00,,CONCORDBIO.NS
Other Operating Expenses,2021-03-31 00:00:00,,CONCORDBIO.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,CONCORDBIO.NS
Amortization,2021-03-31 00:00:00,32580000.0,CONCORDBIO.NS
Depreciation Income Statement,2021-03-31 00:00:00,,CONCORDBIO.NS
Selling General And Administration,2021-03-31 00:00:00,204570000.0,CONCORDBIO.NS
Selling And Marketing Expense,2021-03-31 00:00:00,133630000.0,CONCORDBIO.NS
General And Administrative Expense,2021-03-31 00:00:00,70940000.0,CONCORDBIO.NS
Rent And Landing Fees,2021-03-31 00:00:00,40000.0,CONCORDBIO.NS
Gross Profit,2021-03-31 00:00:00,,CONCORDBIO.NS
Cost Of Revenue,2021-03-31 00:00:00,,CONCORDBIO.NS
Total Revenue,2021-03-31 00:00:00,,CONCORDBIO.NS
Operating Revenue,2021-03-31 00:00:00,,CONCORDBIO.NS
